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Abstract The ability of different phosphatidylcholine (PC)
species to inhibit cytokine-induced expression of vascular
cell adhesion molecule 1 (VCAM-1) in human umbilical vein
endothelial cells (HUVECs) was investigated. PC species con-




-1 position and palmitoyl- (DPPC),





-2 position were compared. These PC species were stud-
ied as components of reconstituted high density lipoproteins
(rHDL) (containing apolipoprotein A-I [apoA-I] as the sole
protein) or as small unilamellar vesicles (SUVs). The rHDL
containing PLPC and PAPC inhibited VCAM-1 expression in
activated HUVECs by 95 and 70%, respectively, at an apoA-I






. At this concentration of apoA-I,
POPC rHDL inhibited by only 16% and DPPC rHDL did not
inhibit at all. These differences could not be explained by
differential binding of the rHDL to HUVECs. The same hier-
archy of inhibitory activity was observed when these PC spe-
cies were presented to the cells as SUVs but only when the
SUVs also contained an antioxidant.  It was concluded that
rHDL PC is responsible for their inhibitory activity and that
this varies widely with different PC species.
 
—Baker, P. W.,
K-A. Rye, J. R. Gable, M. A. Vadas, and P. J. Barter.
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Human high density lipoproteins (HDL) inhibit the
cytokine-induced expression of adhesion molecules in en-
dothelial cells (1) in a process that may contribute to their
antiatherogenicity. This inhibition is concentration depen-
dent within the physiological range of HDL concentrations,
although at any given concentration the extent of inhibi-
tion varies widely between preparations of HDL isolated
from different human subjects (2). The reason for this in-
tersubject variation is not known. The demonstration in a
mouse model that HDL inhibits vascular cell adhesion mol-
 
ecule 1 (VCAM-1) expression in endothelial cells in vivo
(3) highlights the importance of understanding more
about this activity of HDL.
In earlier studies of HDL-mediated inhibition of the









of VCAM-1 in human umbilical vein endothelial cells




) the inhibitory activity
of both HDL (2) and reconstituted HDL (rHDL) (4) is un-
affected by replacing all of the HDL apolipoprotein (apo)




) both spherical and discoidal reconsti-





neither the size nor the cholesteryl ester and triglyceride
content of rHDL has any effect on their inhibitory activity
(4). In contrast to these earlier negative findings, we now re-
port that the inhibitory activity of discoidal rHDL is greatly
influenced by its phospholipid composition. Specifically, of
















(PAPC), rHDL containing PLPC or PAPC have a much
greater inhibitory activity than those containing POPC.
MATERIALS AND METHODS
 
Preparation of discoidal rHDL
 
Discoidal rHDL were prepared by the cholate dialysis method
precisely as described (5). Their sole lipid component was 1,2-
 
Abbreviations: HDL, high density lipoproteins; rHDL, reconstituted
high density lipoproteins; apo, apolipoprotein; VCAM-1, vascular cell
adhesion molecule 1; HUVEC, human umbilical vein endothelial cell;
TNF, tumor necrosis factor; IL-1, interleukin 1; PC, phosphatidylcho-



















-glycero-3-phosphocholine; SUV, small unilamel-
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-glycero-3-phosphocholine (DPPC), PAPC, PLPC,
or POPC while their sole protein component was apolipoprotein
A-I (apoA-I) (molar ratio of PC to apoA-I of 100:1). Particles
were also prepared with apoA-I and mixtures of both PLPC and
POPC (molar ratio of PLPC to POPC to apoA-I of 90:10:1,
70:30:1, and 50:50:1). For lipid uptake studies rHDL were pre-









2 acyl group. Some preparations of rHDL also contained the an-
tioxidant, butylated hydroxytoluene (BHT; molar ratio of PC to
BHT to apoA-I of 100:10:1). For binding experiments, apoA-I




I, using Iodobeads as described by the manu-
facturer (Pierce, Rockville, IL). Iodinated apoA-I was then used
to prepare rHDL. Phospholipids were purchased from Sigma
(St. Louis, MO). The apoA-I was purified from human HDL as
described previously (4). After preparation all rHDL were exten-


















(w/v) Chelex (Bio-Rad, Hercules, CA). After dialysis the samples
were protected from light, stored under nitrogen, and used
within 1 week of preparation. Before addition to HUVECs, the
rHDL were dialyzed over 24 h against endotoxin-free phosphate-
buffered saline (PBS) (three times, 1 L each time). The size
distribution of the rHDL was determined by gradient gel electro-
phoresis (6). The number of molecules of apoA-I per rHDL par-
ticle was determined by cross-linking (7).
 
Preparation of small unilamellar vesicles
 
Small unilamellar vesicles (SUVs) containing PAPC, PLPC, or
POPC, and BHT (molar ratio of PC to BHT, 10:1), were pre-
pared in PBS precisely as described by Jonas (8). In some experi-
ments the SUVs were prepared without BHT.
 
HUVEC isolation, culture, and incubation conditions
 
HUVECs were isolated and cultured as described previously
(4). Briefly, confluent preparations of HUVECs (passage 2 –4)








 (5 mL) in PBS, trypsinised













l/well). After a 5-h reattachment period




L) was removed and replaced








L). The cells were then preincubated for 16 h (unless other-





1 (IL-1) (100 U/mL). In some experiments (where indicated)
the medium containing the rHDL was removed, the cells were
washed with PBS, and fresh medium (not containing rHDL) was
replaced before addition of cytokines. Five hours after addition
of cytokine the cell surface expression of VCAM-1 was measured
by flow cytometry as described (4).
 
Binding and PC uptake studies
 
HUVECs were plated onto 6-well gelatin-coated plates at a








 cells/mL (2.5 mL/well). Binding of rHDL
containing iodinated apoA-I to HUVECs, in the absence or pres-





scribed by Vadiveloo and Fidge (9). Binding of labeled rHDL





with the reported affinity of HDL for endothelial membranes
(9–11). Specific binding of labeled rHDL was calculated by sub-
tracting nonspecific binding of labeled rHDL (determined in
the presence of a 50-fold excess of unlabeled rHDL) from total




C by HUVECs from rHDL





















tion the cells were washed extensively with PBS, harvested into a
minimal volume of PBS, and sonicated. Liquid scintillation
counting of an aliquot of the sonicated cells was used to deter-









bound to the cell surface, a possible confounding factor in de-













ANOVA (two-factor with repeated measures) was per formed
with the data analysis package in Microsoft Excel (version 7.0) by
treating all points within a data set as a group. Significance was












Discoidal rHDL containing different PC species
 
Discoidal rHDL were prepared by complexing apoA-I
to a number of different PC species. The rHDL contain-
ing DPPC, PLPC, or POPC were homogeneous in size,
with average Stokes’ diameters of 10.0, 9.5, or 9.9 nm, re-
spectively. In each of these preparations there were two
molecules of apoA-I per particle. The rHDL containing
PAPC were heterogeneous, including several populations
of particles with Stokes’ diameters ranging from 8.5 to
16.4 nm. While most of the PAPC rHDL contained two
molecules of apoA-I per particle, about 20% contained
three or four molecules of apoA-I per particle. The final
molar ratio of PC to apoA-I was about 100:1 in all rHDL
preparations.
 
Inhibition of VCAM-1 expression by rHDL containing 
different PC species
 
HUVECs were preincubated for 16 h with rHDL con-





. Preincubation with PLPC or PAPC rHDL led to a





). In contrast, preincubation with POPC rHDL




-induced VCAM-1 expression. At






 the inhibition achieved
by PLPC, PAPC, and POPC rHDL was 95, 70, and 16%, re-
spectively (Fig. 1).
To determine whether the extent of inhibition was in-
fluenced by the duration of the preincubation, HUVECs
were preincubated with rHDL containing PLPC or POPC




. After 1 h of







rHDL inhibited VCAM-1 expression by 40%; when the
preincubation was extended to 16 h, the inhibition was
95%. At the same concentration of apoA-I, POPC rHDL
inhibited VCAM-1 expression by approximately 16%
when preincubated with the cells for 16 h but did not in-
hibit at all when preincubated for only 1 h (results not
shown).
In all the experiments described so far, the rHDL were





furthermore, the rHDL remained in the medium for the
next 5 h until the incubation was terminated and VCAM-1
expression was determined. In previous studies with HDL,
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in HUVECs persisted even if the HDL were removed from





2, 12). We therefore conducted studies to determine
whether this also applies to discoidal rHDL and, if so,
whether the hierarchy of inhibitory activities observed
above with rHDL containing different PC species persists.
 
Effect of removing rHDL before




These studies were conducted not only with rHDL con-
taining PLPC, PAPC, or POPC as in Fig. 1 but also with
rHDL containing DPPC. HUVECs were preincubated for
16 h with these rHDL preparations before the medium
containing the rHDL was removed, the cells were washed
with PBS, and fresh medium (not containing rHDL) was





expression of VCAM-1 determined 5 h later. Despite being
removed before the cells were activated, rHDL containing





); at an apoA-I concen-






, the inhibition achieved by PLPC and
PAPC rHDL was 53 and 33%, respectively. The rHDL con-
taining POPC had minimal inhibitory activity and those
containing DPPC did not inhibit at all (Fig. 2).
 
Binding of rHDL containing PLPC or POPC to HUVECs
 
Studies were conducted to determine whether the dif-
fering inhibitory activities of rHDL containing PLPC or
POPC were related to differences in their binding to
HUVECs. Binding of rHDL to HUVECs was assessed with





The specific activity of the rHDL apoA-I was approxi-
mately 150 cpm/ng. Specific binding of POPC rHDL





), with approximately 0.03% of
the added rHDL being bound to the cell surface. Compet-
itive binding studies of labeled POPC rHDL in the pres-
ence of an equimolar amount of unlabeled PLPC rHDL
(Fig. 3B, shaded column) and vice versa (Fig. 3B, open
column) demonstrated that each rHDL preparation had a
similar affinity for the cell surface. After incubation all the
unbound apoA-I was recovered in the medium.
 
Cellular uptake of PLPC or POPC from rHDL
 
Having demonstrated that rHDL containing PLPC or
POPC bind with similar affinity to the surface of HUVECs,
studies were conducted to determine the extent to which




C from rHDL containing PLPC or








-2 acyl group. The specific









C the cells were found to














from rHDL containing POPC or PLPC (Fig. 4A). Approxi-
mately 98% of the phospholipid added to the cells was re-
covered in the medium after incubation. When the incu-




C, few counts were associated
with the cells, between 0.02 and 0.03% of the added
counts (Fig. 4B).
Fig. 1. Inhibition of TNF-a-induced VCAM-1 expression in
HUVECs after preincubation with rHDL containing different PC
species. Discoidal rHDL were prepared with POPC (s), PAPC (h),
or PLPC (d) as the sole lipid and apoA-I as the sole protein at a mo-
lar ratio of PC to apoA-I of 100:1, as described in Materials and
Methods. HUVECs were preincubated with the rHDL for 16 h
before being activated with TNF-a. The rHDL remained in the
medium during activation with TNF-a. VCAM-1 expression was de-
termined 5 h after addition of TNF-a. Results are expressed as
means 6 SEM (n 5 4). An asterisk (*) indicates a significantly
greater inhibitory activity when compared with that achieved with
POPC rHDL (P , 0.05, ANOVA).
Fig. 2. Effect of removing the rHDL from the medium before ac-
tivating HUVECs with TNF-a. Discoidal rHDL were prepared with
DPPC (j), PAPC (h), PLPC (d), or POPC (s) as the sole lipid and
apoA-I as the sole protein at a molar ratio of PC to apoA-I of 100:1,
as described in Materials and Methods. HUVECs were preincu-
bated with the rHDL for 16 h. The medium containing the rHDL
was then removed, the cells were washed with PBS, and fresh me-
dium (not containing rHDL) was added before activation of the
cells with TNF-a. VCAM-1 expression was determined 5 h after ac-
tivation with TNF-a. Results are expressed as means 6 SEM (n 5
3). An asterisk (*) indicates a significantly greater inhibitory activ-
ity when compared with that achieved by POPC rHDL (P , 0.05,
ANOVA).
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Effects of discoidal rHDL containing
mixtures of PLPC and POPC
Having observed large differences in the ability of discoi-
dal rHDL containing PLPC or POPC to inhibit endothelial
cell VCAM-1 expression, studies were conducted to investi-
gate the possibility of interactions between these PC spe-
cies. In these studies discoidal rHDL were prepared with
apoA-I and mixtures of PLPC and POPC. The molar ratios
of PLPC to POPC in these mixtures were 100:0, 90:10,
70:30, 50:50, and 0:100. All had a molar ratio of PC to apoA-I
of about 100:1 and comprised single populations of parti-
cles with Stokes’ diameters that increased progressively
from 9.6 nm when the particles contained 100% PLPC to
10.0 nm when the particles contained 100% POPC.
The rHDL containing 100% PLPC inhibited VCAM-1 ex-
pression in a concentration-dependent manner, with the in-
hibition reaching 77% at an apoA-I concentration of 16 mm,
while the rHDL containing 100% POPC achieved minimal
inhibition at this molarity of apoA-I (Fig. 5). Replacement of
10% of the rHDL PLPC with POPC reduced the inhibition
from 77 to 64% at an apoA-I concentration of 16 mm. Re-
placement of 30% of the rHDL PLPC with POPC further re-
duced the inhibition to 51%, while replacement of half the
rHDL PLPC with POPC reduced the inhibition to 31%.
Effects of SUVs containing different PC species
Studies were conducted to determine whether the effects
of discoidal rHDL could be replicated by SUVs composed
of PAPC, PLPC, or POPC. PAPC and PLPC SUVs prepared
without BHT were cytotoxic to HUVECs as judged by trypan
blue exclusion, making it impossible to assess their effects
on adhesion molecule expression. In contrast, PAPC and
PLPC SUVs containing BHT were not cytotoxic (95% via-
bility after 16 h of preincubation) and inhibited the TNF-
a-induced expression of VCAM-1 in a concentration-
dependent manner, comparable to that of PLPC and
PAPC rHDL (Fig. 6). POPC SUVs, with or without BHT,
were not cytotoxic to HUVECs; in neither case did they in-
hibit VCAM-1 expression (Fig. 6). As with PLPC and PAPC
rHDL, the inhibition mediated by PAPC and PLPC SUVs
was apparent whether the SUVs were present during acti-
vation of the cells with cytokine (Fig. 6) or had been re-
moved prior to activation (Fig. 7).
Effects of rHDL and SUVs containing PLPC
or POPC on IL-1-induced VCAM-1 expression
In all the experiments shown above, the HUVECs were
activated with TNF-a. Further experiments were con-
ducted to determine whether the differing inhibitory ac-
tivities of rHDL and SUVs containing PLPC or POPC were
also apparent when IL-1 rather than TNF-a was used to ac-
tivate the cells. In these experiments rHDL (Fig. 7A) or
SUVs (containing BHT) (Fig. 7B) were preincubated with
HUVECs for 16 h. The rHDL and SUVs were then re-
moved, fresh medium (not containing rHDL or SUVs)
was added, and the cells were activated with IL-1. PLPC,
whether present as a component of rHDL or SUVs, inhib-
ited the IL-1-mediated expression of VCAM-1 in HUVECs
in a concentration-dependent manner comparable to that
observed when the cells were activated by TNF-a. Also
Fig. 3. Binding of rHDL containing POPC or PLPC to HUVECs.
Discoidal rHDL were prepared with POPC or PLPC as the sole lipid
and unlabeled apoA-I or 125I-labeled apoA-I as the sole protein at a
molar ratio of PC to apoA-I of 100:1, as described in Materials and
Methods. HUVECs were incubated for 2 h at 48C with labeled
rHDL and specific binding was determined by correcting for non-
specific binding as described in Materials and Methods. (A) Spe-
cific binding of POPC rHDL (shaded column) and PLPC rHDL
(open column). (B) Specific binding of labeled POPC rHDL in the
presence of an equimolar amount of unlabeled PLPC rHDL
(shaded column) and vice versa (open column); rHDL were added
at an apoA-I concentration of 500 nm. Results are expressed as
means 6 SEM (n 5 3).
Fig. 4. Uptake of rHDL PC by HUVECs. Discoidal rHDL were
prepared with POPC or PLPC labeled with 14C in the sn-2 acyl
group as the sole lipid and unlabeled apoA-I as the sole protein at a
molar ratio of PC to apoA-I of 100:1, as described in Materials and
Methods. HUVECs were incubated with labeled rHDL for 16 h at
378C (A) or for 2 h at 48C (B). The uptake of 14C by the cells was
then determined as described in Materials and Methods. Results
are expressed as means 6 range (duplicate determination).
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consistent with the results with TNF-a, POPC had little to
no effect on the IL-1-induced expression of VCAM-1,
whether present during preincubation as a component of
rHDL or SUVs (Fig. 7).
DISCUSSION
These studies demonstrate for the first time that three
of the more abundant PC species in human HDL, PAPC,
PLPC, and POPC (13, 14), differ markedly in their abili-
ties to inhibit the TNF-a-induced expression of VCAM-1
in HUVECs. These differences were observed whether the
PC species were presented to the cells as components of
discoidal rHDL or as SUVs and they could not be ex-
plained by differences in rHDL binding to the cells or the
uptake of rHDL PC by the cells. PAPC and PLPC were cy-
totoxic to HUVECs unless they were components of rHDL
in which they were complexed to apoA-I or were compo-
nents of SUVs that also contain the antioxidant BHT. This
latter observation is consistent with reports that apoA-I
has antioxidant properties (15). It may also explain why
low density lipoproteins (LDL), whose lipids are more
readily oxidisable than the lipids in HDL (16), do not in-
hibit adhesion molecule expression (17, 18).
We have reported that both HDL and rHDL inhibit en-
dothelial sphingosine kinase (SKase) (12). SKase is an en-
zyme that catalyses a key step in the pathway by which
TNF-a stimulates endothelial cell VCAM-1 and E-selectin
expression (19). The precise mechanism by which HDL
interact with the cell to achieve this inhibition is still not
known. There is good evidence, however, that it does not
involve interference by HDL with the binding of TNF-a to
the cell surface (12). This conclusion is supported by the
observation in the present study that the inhibitory activity
of both rHDL and SUVs remained apparent even when
they were removed before the cells were activated with
TNF-a or IL-1.
The explanation for the differing inhibitory activities of
rHDL and SUVs containing different PC species is not
known. Regardless of the mechanism, however, the obser-
vation has obvious pathophysiological implications. About
80% of the phospholipid in human HDL is PC, with PLPC
accounting for about 40% of the PC (13, 14). The impor-
tance of the fatty acid composition of plasma phospholip-
ids [which reflects that of HDL phospholipids (13, 14)]
has been highlighted in population studies in which the
linoleic acid composition of phospholipids is predictive of
the development of coronary heart disease (20–23). It
will, therefore, be of considerable interest to determine
whether differing inhibitory activities of HDL isolated
from different human subjects (2) can be explained by
variations in the composition of HDL phospholipids. It
will also be worth investigating whether differences in
phospholipid composition can explain the superior inhib-
itory activity of HDL3 compared with that of HDL2 (2).
When the different PC species were presented to the
cells as components of SUVs, the hierarchy of inhibitory
activities was the same as that observed when they were
Fig. 5. Inhibition of TNF-a-induced VCAM-1 expression in
HUVECs by preincubating the cells with rHDL containing mix-
tures of POPC and PLPC. Discoidal rHDL were prepared with
apoA-I and mixtures of PLPC and POPC at a molar ratio of PC to
apoA-I of 100:1, as described in Materials and Methods. HUVECs
were preincubated with the different preparations of rHDL for 16 h
before being activated with TNF-a. The rHDL remained in the me-
dium during activation of the cells with TNF-a. VCAM-1 expression
was determined 5 h after addition of TNF-a. The molar ratios of
PLPC to POPC to apoA-I in the different rHDL preparations were
100:0:1 (d), 90:10:1 (j), 70:30:1 (n), 50:50:1 (h), and 0:100:1 (s).
Results are expressed as means 6 SEM (n 5 3). The inhibition me-
diated by all rHDL preparations was significantly greater than that
observed with rHDL containing 100% POPC (P , 0.05, ANOVA).
Fig. 6. Inhibition of TNF-a-induced VCAM-1 expression in
HUVECs after preincubation with SUVs containing different PC
species. SUVs were prepared with PAPC (h), PLPC (d), or POPC
(s) as the sole lipid and BHT as an antioxidant at a molar ratio of
PC to BHT of 10:1, as described in Materials and Methods. HUVECs
were preincubated with the SUVs for 16 h before being activated
with TNF-a. The SUVs remained in the medium during activation
with TNF-a. VCAM-1 expression was determined 5 h after addition
of TNF-a. Results are expressed as means 6 SEM (n 5 3). An aster-
isk (*) refers to a significant difference in inhibitory activity com-
pared to POPC rHDL (P , 0.05, ANOVA).
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components of rHDL. This raises the possibility that PC
may be the active component of HDL responsible for its
inhibitory activity. The fact that these PC species as com-
ponents of SUVs are effective only in the presence of an
antioxidant suggests that the inhibitory activity of the PC
in HDL may depend on it being protected by the antioxi-
dant properties of these lipoproteins (15, 16, 24).
The cytokine-induced expression of endothelial cell
VCAM-1 is also inhibited by nonesterified fatty acids
(NEFA) (25, 26). Consistent with the inhibition by phos-
pholipids in the present study, the inhibition by nonesteri-
fied linoleic acid is superior to that of nonesterified oleic
acid (26). There are, however, clear differences between
the inhibition mediated by NEFA and that mediated by
the PC associated with HDL. For example, there is no evi-
dence of a lag phase with the inhibition mediated by HDL
(1) or rHDL, whereas the inhibition mediated by NEFA
occurs only after a lag phase of about 6 h (25). In addi-
tion, maximal inhibition of VCAM-1 expression by NEFA
requires preincubation for 48–72 h (25, 26) compared
with 16 h or less in the case of HDL or rHDL (1, 2, 4). In-
terestingly, the time course for the inhibitory effects of
NEFA parallels that of their incorporation into cellular
lipids (25). We postulate that the importance of HDL in
this process relates to their ability to transport PC in an
environment in which it is protected against oxidation
prior to being delivered to endothelial cells.
The pathophysiological relevance of these findings to
the ability of HDL to protect against atherosclerosis re-
mains to be determined. Although the results of in vivo
studies are conflicting (3, 27–29), several studies have
shown that HDL do inhibit endothelial cell adhesion mol-
ecule expression in vivo (3, 27, 28). To the extent that this
antiinflammatory property of HDL is antiatherogenic, the
present studies suggest that the phospholipid composition
may be of greater importance than previously recognized.
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